Roman Health Pharmacy LLC
“you may select Roman Health Pharmacy LLC or one of our partner pharmacies (collectively, the 'Ro Pharmacy Network')”
Source: ro.co · Verified 2026-05-23

GLP-1 weight-loss telehealth · Independently scored 6.7/10
Best for: knowing which pharmacy fills the vial — it names Roman Health Pharmacy LLC
Ro's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
No insurance needed · Vetted by our editors
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Six columns, each one computed from something Ro has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
$149/month is exactly the register median for brand orforglipron.
Dispenses orforglipron, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
On the seller's own pages, a price is published before the questionnaire starts.
names its dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
The price covers consult, labs, coaching.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Prices re-verified
Additional membership fees apply
Check the price yourself before you pay
Every figure here was read off Ro's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Each partner below is a 503A or 503B pharmacy that Ro routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
“you may select Roman Health Pharmacy LLC or one of our partner pharmacies (collectively, the 'Ro Pharmacy Network')”
Source: ro.co · Verified 2026-05-23
The standing price at Ro is $149/month. That sits at the affordable end of what we track.
Across the GLP-1 providers in our register the median standing price is about $169/month, so Ro is genuinely under the middle rather than merely advertising that it is.
Found, at about $149/month, is the closest thing we track to a like-for-like alternative.
Ro prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the vial has been reviewed.
On the record: it names the pharmacy that fills its prescriptions and coaching is included rather than sold on top. We searched the federal warning-letter record for this operator and came back with nothing. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Ro competes on price and does it without an obvious sacrifice elsewhere: $149/month, no warning letter on file, and access that is not unusually restricted.
The Bottom Line
Ro's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Starting at $149/month. Check today's price, then book the free consultation.
The words sellers use, defined. Tap any term.
Cited across this Ro review: primary regulatory filings, and peer-reviewed studies.
Plans start at $149/month. The free consultation is where you learn whether you qualify, and what it costs today.